May 19, 2026 ScienceFast-tracking genetic leads to reverse cellular aging ShareTwo of the biggest bottlenecks in aging research are deciding which genetic pathways to test and making sense of the vast data those experiments produce. Biologists Omar Abudayyeh and Jonathan Gootenberg are using Co-Scientist to help them blast through both.Their lab runs huge genetic screens that flip thousands of genes on or off then reads how cells respond to these changes. The goal is to find changes that push cells away from senescence – a damaged state linked to aging – and toward a youthful state in tissues such as skin, hair, and muscle.Co-Scientist is helping on two fronts. First, it generates leads. When the team asked it to trawl the scientific literature for factors that might reverse aging, it scanned tens of thousands of papers, considered a multitude of hypotheses, and ultimately proposed more than 20 novel, plausible genetic factors to test. Lab tests validated a couple Co-Scientist’s hypotheses, with its recommended factors successfully driving cells into a younger state with improved overall function.Second, Co-Scientist speeds up the follow-through. Once the team has results from a big screen, they have to figure out what the enormous amount of data might mean, and which directions are worth pursuing next. That kind of analysis – trying to connect test results to years of scattered scientific literature – can take a researcher up to six months. Having Co-Scientist analyse their screening data alongside the literature, that work is slashed to just a few days.Slide 1 of 2Using Co-Scientist feels like having a team of 50 people at your disposal, doing all the work within a day, which isn’t something we can otherwise do with our lab. Omar Abudayyeh, Principal Investigator The Abudayyeh–Gootenberg Lab There are so many unanswered questions in biology. We’re looking for paradigm‑shifting things – monumental discoveries – and I think Co‑Scientist will enable those. Jonathan Gootenberg, Principal Investigator The Abudayyeh–Gootenberg Lab Related postsCo-Scientist: A multi-agent AI partner to accelerate researchMay 2026Science Learn more Uncovering repurposed medicines to fight liver fibrosisMay 2026Science Learn more Uniting biological toolkits for a new approach to ALSMay 2026Science Learn more Accelerating discovery of liver disease mechanismsMay 2026Science Learn more Opening new paths in aging researchMay 2026Science Learn more Finding the molecular switches behind new infectious diseasesMay 2026Science Learn more
Co-Scientist
Accelerating cellular aging research
Related
ResearchLearning When to Trust via Selective Context Preference Optimization
Language models increasingly condition their answers on external signals, and a single misleading one can turn a correct answer wrong. The obvious remedy, training models to resist such signals, hides a failure mode: a model that ignores all context looks robust yet is useless when the context is worth trusting. We recast the problem as selective trust and introduce MIST, a human-annotated benchmark that renders each reasoning item under four matched conditions (clean, misleading, correct-context, and irrelevant-context), together with SC2W, a paired metric counting how often a misle
Learning When to Trust via Selective Context Preference Optimization
Language models increasingly condition their answers on external signals, and a single misleading one can turn a correct answer wrong. The obvious remedy, tr...
ResearchTracing the Heart: An Evidence-Linked Pipeline for Heart-Failure Feature Engineering
Electronic health record (EHR) feature engineering is a major bottleneck in clinical research and AI, accounting for 39-45% of data scientists' workload. This is especially pronounced in heart failure, which affects an estimated 6.7 million U.S. adults and requires integrating fragmented EHR data with disease-specific, guideline-based clinical reasoning. Existing rule-based and large language model (LLM)-based approaches offer only partial automation with limited maintainability and evidence traceability. We developed the Nimblemind Multi-Agent System (nMAS), an evidence-linked, rubr